Dr. Daniel Blumberger Joins Sooma’s Science Advisory Board
Welcoming A Pioneer in Neuromodulation Research
Sooma Medical is proud to announce a significant addition to our team with the appointment of Dr. Daniel Blumberger to our Science Advisory Board. As the Scientific Director of the Temerty Centre for Therapeutic Brain Intervention and a distinguished figure in the field of neuromodulation, Dr. Blumberger’s wealth of expertise and research acumen will undoubtedly enhance our commitment to innovative solutions for mental health.
About Dr. Daniel Blumberger
Dr. Blumberger is the scientific director of the Temerty Centre for Therapeutic Brain Intervention, co-chief of General Adult Psychiatry and Health Systems, and a senior scientist at the Centre for Addiction and Mental Health (CAMH). He additionally holds the Temerty Chair in Therapeutic Brain Intervention at CAMH. He is a subspecialist in geriatric psychiatry, a professor in the Department of Psychiatry in the Temerty Faculty of Medicine at the University of Toronto, and a full member of the Institute of Medical Sciences.
Research Focus
Dr. Blumberger’s research is at the forefront of interventional psychiatry, with a specific focus on brain stimulation therapies for refractory psychiatric disorders. His primary research areas focus on clinical intervention trials of novel treatments and a comprehensive understanding of the neurobiology of treatment-resistant depression across the lifespan.
Clinical Trials and Innovations
As the principal investigator or co-investigator on multiple clinical trials, Dr. Blumberger has been at the forefront of exploring diverse brain stimulation modalities and novel drug approaches. His contributions encompass electroconvulsive therapy (ECT), ketamine, magnetic seizure therapy (MST), psilocybin, repetitive transcranial magnetic stimulation (rTMS), and transcranial direct current stimulation (tDCS).
Advancing Mental Health Together
Sooma Medical is honored to welcome Dr. Daniel Blumberger to our Science Advisory Board. His profound expertise, extensive research contributions, and dedication to advancing mental health align seamlessly with our mission. We look forward to the collaborative strides we will make in democratizing brain stimulation therapies for clinicians and patients with Dr. Blumberger’s guidance.
To learn more about Dr. Daniel Blumberger and view his numerous publications, please visit our Science Advisory Board Page
Latest news
Sooma Partners with JSTT to Introduce Brain Stimulation Treatments in Occupational Healthcare
Read more
Prioritizing Youth Mental Health: A Call to Action
Read more
Sooma Secures €5M Funding for At-home Brain Stimulation Therapies
Read more